"When we asked Cramer and CNBC for their own records of Mad Money's stock-picking performance, they had more excuses than a Tour de France cyclist dodging a blood test."
It's bad enough when I get more science news and info about biotech companies by reading this message board than reading the general newspapers, now I have to read about CNBC being compared to blood doping excuses.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.